Dataset for Comparing Daytime Sleepiness in Parkinson Disease by Narcolepsy HLA DQB1 Risk and Protective Alleles

Data on daytime sleepiness in patients with Parkinson disease, narcolepsy HLA DQB1 risk and protective alleles and dopaminergic drug use. The data was collected in a convenience sample of 150 participants with Parkinson disease from Albany Medical Center, Albany, New York. Data available for each participant includes demographic data, past medical history, medications, the Unified Parkinson Disease Rating Scale, Schwab and England scale, Hoehn and Yahr scale, the Montreal Cognitive Assessment, the modified Epworth Sleepiness Scale, the Parkinson Disease Sleep Scale version 2, the Mayo Sleep questionnaire (select questions). Dopaminergic drugs are expressed are levodopa equivalent daily dosage. All participants were genotyped for narcolepsy DQB1 risk alleles. A data dictionary is included.